Beyond BRCA1/2: Clinician-reported utility 3 years post panel testing

Autor:	Rachel Pearlman, Heather Hampel, Rosalba Sacca, Robert Pilarski, Katherine A. Schneider, Pamela Brock, Edward D. Esplin, Whitney Espinel, Diane R. Koeller, Kevin Sweet, Lindsay Kipnis, Anu Chittenden, Joanne M. Jeter, Marjan Champine, Jill Stopfer, Shraddha Gaonkar, Jilliane Sotelo, Kate P Shane-Carson, Judith A. Westman, Samantha Stickevers
Rok vydání:	2018
Předmět:	Cancer Research endocrine system diseases Oncology business.industry Medicine skin and connective tissue diseases Bioinformatics business Penetrance Germline
Zdroj:	Journal of Clinical Oncology. 36:e18705-e18705
ISSN:	1527-7755 0732-183X
Popis:	e18705Background: Germline testing guidelines are centered on BRCA1 and BRCA2 despite clear medical management recommendations in several other high and moderate penetrance genes. Clinician utiliza...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f63dfee931a10ef82c1fbe719bd8d505 https://doi.org/10.1200/jco.2018.36.15_suppl.e18705 Zobrazit plný text záznamu